Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study

BACKGROUND: This phase 3 study evaluated the efficacy and safety of 6-month treatment with romosozumab in Korean postmenopausal women with osteoporosis. METHODS: Sixty-seven postmenopausal women with osteoporosis (bone mineral density [BMD] T-scores ≤−2.5 at the lumbar spine, total hip, or femoral n...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrinol Metab (Seoul)
Autors principals: Baek, Ki-Hyun, Chung, Yoon-Sok, Koh, Jung-Min, Kim, In Joo, Kim, Kyoung Min, Min, Yong-Ki, Park, Ki Deok, Dinavahi, Rajani, Maddox, Judy, Yang, Wenjing, Kim, Sooa, Lee, Sang Jin, Cho, Hyungjin, Lim, Sung-Kil
Format: Artigo
Idioma:Inglês
Publicat: Korean Endocrine Society 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7937846/
https://ncbi.nlm.nih.gov/pubmed/33677928
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2020.848
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars